WellDoc BlueStar vs Cardiomo

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by WellDoc
VS
by Cardiomo, Inc.

AI Verdict

WellDoc BlueStar is an FDA-cleared digital health solution focused on comprehensive chronic disease management for conditions like diabetes, hypertension, and heart failure, offering personalized coaching and insights through a mobile app and web platform. Cardiomo, while also FDA-cleared, specializes in continuous and remote heart health monitoring via a medical-grade wearable device, primarily detecting cardiovascular diseases and providing real-time alerts. While both utilize AI and address cardiovascular health, WellDoc BlueStar offers broader chronic care management, whereas Cardiomo provides specialized, continuous cardiac monitoring through a wearable device.

Choose WellDoc BlueStar if…

Choose WellDoc BlueStar if your organization requires a comprehensive, AI-powered digital health solution for managing multiple chronic conditions like diabetes, hypertension, and heart failure across a patient population. Its strength lies in personalized coaching, integration with various connected devices, and robust support for care teams through a provider portal and SMARTVisit reports, making it ideal for health plans, health systems, or employers focused on broad chronic disease management and patient engagement.

View WellDoc BlueStar →

Choose Cardiomo if…

Choose Cardiomo if your primary need is continuous, medical-grade remote heart health monitoring with a focus on early detection of cardiovascular diseases and real-time alerts. Its wearable patch and AI engine are specifically designed for vital sign monitoring (ECG, heart rate, respiration) and immediate notifications for potential cardiovascular events, making it particularly well-suited for individuals at risk of heart conditions, geriatrics, or situations where proactive, continuous cardiac oversight is critical.

View Cardiomo →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature WellDoc BlueStar Cardiomo
Pricing Enterprise pricing; paid by health plans, health systems, or employers. Contact for pricing
Deployment Mobile app (iOS, Android) and web-based platform Cloud-based with wearable device and mobile app
FDA Status 1 AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

WellDoc BlueStar

WellDoc BlueStar offers a comprehensive mobile app and web platform for multi-condition management, integrating with a wide range of connected devices. This broad integration and platform approach likely provides a more versatile and user-friendly experience for managing multiple chronic conditions compared to Cardiomo's primary focus on a wearable device for heart monitoring.

Clinical Value

WellDoc BlueStar

WellDoc BlueStar is FDA-cleared and provides AI-driven personalized coaching, multi-condition support, and insulin dose recommendations, directly impacting chronic disease management. While Cardiomo offers medical-grade continuous monitoring and disease detection, WellDoc's direct therapeutic recommendations and broader scope for chronic conditions suggest a more immediate and comprehensive clinical value for ongoing patient management.

Pricing & Value

Tie

Both tools primarily use enterprise pricing models, requiring direct contact for details, making a direct comparison of value difficult. Cardiomo previously had a consumer-facing price, but current details are unavailable. Without transparent pricing for either, it's impossible to determine which offers better value.

Enterprise Readiness

WellDoc BlueStar

WellDoc BlueStar explicitly states its pricing model is for health plans, health systems, or employers, indicating a strong enterprise focus. It also features a care team portal and SMARTVisit reports, which are crucial for integration into existing healthcare workflows. Cardiomo's enterprise readiness is less explicitly detailed beyond its HIPAA compliance and cloud analytics.

Innovation

Tie

WellDoc BlueStar demonstrates innovation through its AI-driven personalized coaching across multiple chronic conditions and FDA-cleared insulin dose recommendations. Cardiomo is innovative with its medical-grade wearable for continuous vital sign monitoring and AI-powered real-time disease detection. Both represent significant advancements in their respective domains within healthcare AI.

Support & Docs

Tie

Neither the provided structured facts nor general web searches offer specific details about the level of customer support, technical documentation, or training resources available for either WellDoc BlueStar or Cardiomo. Without this information, it is not possible to determine a winner in this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature WellDoc BlueStar Cardiomo
Name WellDoc BlueStar Cardiomo
Company WellDoc Cardiomo, Inc.
Description WellDoc BlueStar is an FDA-cleared, AI-powered digital health solution for chronic disease management, offering personalized coaching and insights for conditions like diabetes, hypertension, and heart failure. Cardiomo offers a medical-grade wearable device and an AI-powered platform for continuous and remote heart health monitoring, designed to detect cardiovascular diseases and provide timely alerts to users and caregivers.
Key Features AI-driven personalized coaching, Multi-condition support (diabetes, hypertension, heart failure, weight management, behavioral health), Integration with connected devices (BGM, CGM, BP cuffs, weight scales, activity trackers, insulin pens), Insulin dose recommendations (bolus, basal, premixed), Real-time feedback and educational content, Care team portal for providers (Management Portal), SMARTVisit reports for healthcare providers, Data logging capabilities (glucose, BP, weight, sleep, meals, exercise) Medical-grade wearable patch, Continuous vital sign monitoring (ECG, heart rate, respiration, skin temperature), AI-powered disease detection (arrhythmias, cardiovascular events), Real-time alerts and notifications, Mobile application (Android and iOS), HIPAA-compliant cloud analytics, Fall detection, Long battery life (up to 7-10 days)

Videos

Demos, reviews, and walkthroughs featuring WellDoc BlueStar and Cardiomo.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

WellDoc BlueStar offers a Care Team Portal for providers and SMARTVisit reports, suggesting integration capabilities to share patient data and insights with the care team. Cardiomo's platform is cloud-based with a mobile app, and while it mentions HIPAA-compliant cloud analytics, the specifics of EHR integration depth and data exchange are not detailed in the provided information.
WellDoc BlueStar provides AI-driven personalized coaching and insulin dose recommendations, implying a level of accuracy in its algorithms for chronic disease management. Cardiomo utilizes an AI engine for continuous vital sign monitoring and disease detection, specifically for arrhythmias and cardiovascular events, suggesting a focus on the accuracy and sensitivity of its detection capabilities for cardiac conditions.
WellDoc BlueStar, with its multi-condition support for diabetes, hypertension, and heart failure, along with insulin dose recommendations, appears well-suited for endocrinologists and internal medicine physicians managing complex cardiometabolic conditions. Cardiomo, focused on continuous vital sign monitoring and detection of cardiovascular events, seems more aligned with the workflow of cardiologists and geriatrics specialists for proactive heart health management.
WellDoc BlueStar offers a Care Team Portal and SMARTVisit reports, which would likely require some training for providers to effectively utilize the data and insights. Cardiomo's system involves a wearable device and a mobile application, which may require physicians and patients to learn how to interpret alerts and data. Specific details on onboarding and ongoing support quality are not provided for either tool.
WellDoc BlueStar's Care Team Portal and SMARTVisit reports suggest a level of data logging and reporting that could potentially include audit-trail features for provider actions and patient progress. Cardiomo's continuous monitoring and real-time alerts imply a robust data logging system, but specific audit-trail features are not explicitly mentioned for either tool.
WellDoc BlueStar's enterprise pricing and focus on health plans and health systems suggest it is designed for larger-scale deployments, implying considerations for multi-site rollouts. Cardiomo's cloud-based platform and wearable device model could also support multi-site rollouts, but specific considerations for large-scale implementation are not detailed for either product.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.